Skip to main content
Clinical Trials/CTRI/2023/04/051461
CTRI/2023/04/051461
Not yet recruiting
未知

The objective of this study will be to evaluate efficacy of Prinourish Skin- Enriching Superfood Serum in terms of visible reduction in fine lines and wrinkles, visible reduction in dark spots, reduction in visible appearance of pore, reduction in appearance of open and closed comedons, improvement in skin moisturization and even skin tone on healthy female subjects

Transformative Learning Solution Pvt Ltd0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Transformative Learning Solution Pvt Ltd
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Transformative Learning Solution Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • 1\)Indian Female subjects
  • 2\)Healthy subjects (no infectious and evolutive pathology which could make the subject vulnerable and
  • stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory checkup)
  • 3\)Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar)
  • 4\)Having wrinkles and fine lines, dark spots, dry skin, visible pores, open and closed comedons

Exclusion Criteria

  • 1 Female subjects who are pregnant (determined by Urine pregnancy test) or breastfeeding or having stopped to breastfeed in the past three months
  • 2 Having refused to give her assent by not signing the consent form
  • 3 Taking part in another study liable to interfere with this study
  • 4 Being insulin\-dependent diabetic or non insulin\-dependent diabetic with a recent therapy (less than 6 months)
  • 5 Having a progressive asthma (either under treatment or last fit in the last 2 years)
  • 6 Being epileptic.
  • 7 Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months)
  • 8 Having cutaneous hypersensitivity
  • 9 Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products.
  • 10 Having known allergy to any of the Ingredient of the Test Product

Outcomes

Primary Outcomes

Not specified

Similar Trials